| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.44 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |